Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/3/25 19:51 | 7/1/25 | PMVP | Health | Drug | Pharmaceutical Preparations | Ticktin Robert | NJ | O | GC,COO | 1 | S | -25 | 1.06 | 0 | -23 | 99 | D | |||||||||||||||
7/3/25 19:50 | 7/1/25 | PMVP | Health | Drug | Pharmaceutical Preparations | Jalota Deepika | NJ | O | Chief De | 1 | S | -35 | 1.06 | 0 | -33 | 90 | D | |||||||||||||||
7/3/25 19:49 | 7/1/25 | PMVP | Health | Drug | Pharmaceutical Preparations | Carulli Michael | NJ | O | CFO | 1 | S | -30 | 1.06 | 0 | -28 | 60 | D | |||||||||||||||
7/3/25 19:48 | 7/1/25 | PMVP | Health | Drug | Pharmaceutical Preparations | Mack David Henry | NJ | DO | P,CEO | 1 | S | -62 | 1.06 | 0 | -58 | 906 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |